Technical Analysis for EDAP - EDAP TMS S.A.

Grade Last Price % Change Price Change
D 5.97 0.67% 0.04
EDAP closed up 0.67 percent on Friday, May 14, 2021, on 74 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Flat Down Down
Historical EDAP trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Crossed Above 200 DMA Bullish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish 0.67%
Expansion Breakdown Bearish Swing Setup 0.67%
Wide Bands Range Expansion 0.67%
Down 3 Days in a Row Weakness 0.67%
Down 4 Days in a Row Weakness 0.67%
Older End-of-Day Signals for EDAP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day 3 days ago
Up 3% 3 days ago
60 Minute Opening Range Breakout 3 days ago
Up 2% 3 days ago
200 DMA Support 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

EDAP TMS S.A. Description

EDAP TMS S.A., through its subsidiaries, engages in the development, production, marketing, distribution, and maintenance of minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions, High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division offers medical devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. This division provides Ablatherm, a HIFU-based ultrasound guided device for the treatment of organ-confined prostate cancer. Its HIFU technology allows the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division also engages in the leasing of equipment, as well as the sale of disposables, spare parts, and maintenance services. It markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. The UDS division provides medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. This division manufactures lithotripters, including the Sonolith i-move and the Sonolith i-sys, for the treatment of urinary tract stones by means of ESWL technology. It is also involved in the leasing of lithotripters, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct sales and service platform, as well as through agents and third-party distributors. The company's customers include public and private hospitals, urology clinics, and research institutions worldwide. EDAP TMS S.A. was founded in 1979 and is based in Vaulx-en-Velin, France.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinics Prostate Cancer Direct Marketing Urology Ultrasound Magnetic Resonance Imaging Urological Disorders Organs Lath Medical Ultrasonography High Intensity Focused Ultrasound Invasive Medical Devices Urological Diseases Localized Tumors Minimally Invasive Medical Devices

Is EDAP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.68
52 Week Low 2.13
Average Volume 300,227
200-Day Moving Average 5.94
50-Day Moving Average 7.95
20-Day Moving Average 7.09
10-Day Moving Average 6.44
Average True Range 0.53
ADX 29.23
+DI 12.50
-DI 31.59
Chandelier Exit (Long, 3 ATRs ) 7.65
Chandelier Exit (Short, 3 ATRs ) 7.19
Upper Bollinger Band 8.68
Lower Bollinger Band 5.49
Percent B (%b) 0.15
BandWidth 45.04
MACD Line -0.62
MACD Signal Line -0.53
MACD Histogram -0.088
Fundamentals Value
Market Cap 173.98 Million
Num Shares 29.1 Million
EPS -0.06
Price-to-Earnings (P/E) Ratio -101.19
Price-to-Sales 2.64
Price-to-Book 4.01
PEG Ratio 90.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.42
Resistance 3 (R3) 6.43 6.29 6.35
Resistance 2 (R2) 6.29 6.18 6.29 6.32
Resistance 1 (R1) 6.13 6.10 6.06 6.12 6.29
Pivot Point 5.99 5.99 5.96 5.99 5.99
Support 1 (S1) 5.83 5.88 5.76 5.82 5.65
Support 2 (S2) 5.69 5.80 5.69 5.62
Support 3 (S3) 5.53 5.69 5.60
Support 4 (S4) 5.52